SIRT6 and Parkinson disease: To further evaluate the effect of SIRT6 on the nephroprotection of PD (40 mg/kg) in CP-AKI mice in vivo, the mice were orally administered OSS-128167 (50 mg/kg) through gavage 1 h before CP (20 mg/kg) injection (Figure 7(a)).